Flunisolide Articles
Flat 2nd-qtr sales/EPS at Schering-Plough
25 July 2001
Ph I results with Palatin's ED drug PT-141
7 June 2001
Forest's flunisolide HFA approvable in USA
21 May 2001
AstraZeneca hit by slip in Losec sales
26 April 2001
Manufacturing woes hit Schering-Plough
18 April 2001
Aventis to boost Allegra production
16 March 2001
AstraZeneca files for Zomig nasal spray
22 November 2000
Novartis' Miacalcic shows 36% reduction in fractures
19 October 2000
Stock Commentary Tokyo
5 October 2000
Elan Corp set to acquire Dura Pharmaceuticals in $1.8 billion deal
11 September 2000
Palatin cleared to begin trials of PT-141
29 June 2000
Hong Kong pharmacy call to ease OTC regs
1 March 2000
Agouron boosted on drug for common cold
16 December 1999
Tamiflu approved in the USA
28 October 1999
Rhinocort Aqua approved in USA
11 October 1999
Merck and Novartis battle over drug trial
17 June 1999
Agouron Unveils Common Cold Drug
13 October 1998
New Drugs, Vaccine Shift Balance In War Against Flu
30 September 1998
Major Vaccine Deals For France's Biovector
24 September 1998
Novartis' Miacalcic Nasal Spray - Four-Year Results
17 September 1998
Finland May Delay Approval Of Cortecs' Macritonin
17 September 1998
CFC-Free Flunisolide
10 September 1998
Aviron's FluMist "Non-Filable," Says FDA
2 September 1998
New Indication Sought For Miacalcin
17 July 1998
US Quarterly Financial Results Round-Up
23 April 1998
Naratriptan Launched In The USA
26 March 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Forest Files Two New Applications For Aerobid
16 February 1998
GW's Naratriptan Approved In The USA
12 February 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
Top Pharma & Biotech Stock Picks For 1998
4 February 1998
Highlights Of Astra's Pipeline Presentation
30 January 1998
News In Brief
11 December 1997
GW's Nasal Spray Is Launched
4 December 1997
News In Brief
7 November 1997
Boehringer Ingelheim's BIRR 4 Cold Therapy
9 October 1997
FDA And GW Put Beconase OTC Switch On Hold
11 September 1997
GW's Imitrex Approved In USA
4 September 1997
Smaller US Firms' Losses Grow Due To R&D Costs
31 July 1997
P&U's Nicotrol Inhaler Launched In USA
19 May 1997
Dura To Acquire Syntex' Naserel And Nasalide
19 May 1997
Investors Impressed With Glaxo Wellcome Pipeline
12 May 1997
S-P's Nasonex Cleared In First Markets
21 April 1997
R-PR Launches Nasacort In The UK
17 March 1997
Glaxo Wellcome Launches Imigran Nasal Spray In UK
10 March 1997
Carter-Wallace's Astelin Launched In USA
3 March 1997
S-P Targets Psoriasis With Mometasone
24 February 1997
GW's Imigran Approved In 12 EU Countries
6 January 1997
Further Profits Warnings From Forest Labs
9 December 1996
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
R-PR Submits Two Supplementary NDAs
28 October 1996
Novartis Partners 9 Months Figures Disappoint
28 October 1996
S-P File NDA To FDA For Nasonex
14 October 1996
First Clearance For Imigran Nasal Spray
24 June 1996
Schering-Plough Chief Gives R&D Update
10 June 1996
P&U Seeks Approval For Inhaled Nicotine
10 June 1996
US FDA Approves McNeil's Nicotrol NS
1 April 1996
Astelin Approvable In USA
4 March 1996
Cephalon To Promote B-MS Antidepressant
4 March 1996
Eurand's Oral Calcitonin
12 February 1996
Sandoz Launches Nasal Calcitonin In USA
18 December 1995
Carter-Wallace's Astelin Nears Approval
27 November 1995
Sandoz 9 Months Sales up 6%
6 November 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
Bayer: ICAM-1 news
25 September 1995
Sandoz' Calcitonin Spray Approved
11 September 1995
US OK For Miacalcin
4 September 1995
Glaxo Wellcome Takes Hanson's Bonham On Board
10 July 1995
Euro Osteoporosis Market Fuelled By HRT And Aging
12 June 1995
Sandoz Receives Recommended Approval In USA
6 March 1995
Merck's Alendronate: Filing In USA Soon?
27 February 1995
UK POM-To-P Switches At End-1993
2 January 1995
Flonase Launch In USA
19 December 1994
Calcitonin Nasal Spray Set For US Approval?
28 November 1994
McNeil To Market Nicotine Nasal Spray
21 November 1994
Glaxo Receives Approval For Flonase
31 October 1994
ASTA Medical Launch In France
24 October 1994
Canada: Province's "Secret Pact With Drug Firms"
24 October 1994
FDA Considers Nicotine Nasal Spray
22 August 1994
Cephalon Starts Phase III Modafinil Trials
15 August 1994
Strong Gains By US Firms In 2nd Quarter
1 August 1994
Felbatol Approval Marks Year At Carter-Wallace
1 August 1994
GLAXO CLOSER TO OTC RANITIDINE
11 July 1994
MEDEVA ACQUIRES MERCK PRODUCTS
6 June 1994
DESMOPRESSIN NASAL SPRAY
9 May 1994
UNCERTAINTY OVER SWEDISH OTC PLANS
9 May 1994
NASAL SPRAY FOR RSV INFECTION TESTED
21 February 1994
OTC BECONASE TO BECOME AVAILABLE
14 February 1994
AVIRON WORKING ON NASAL FLU VACCINE
13 December 1993
NEW UK LIMITED LIST DETAILS ANNOUNCED
25 October 1993
UK TO DELIST 62 MORE MEDICINES FROM NHS
23 August 1993
DURA ABANDONS PENTYDE
9 August 1993
ROUND UP OF PRODUCT SWITCHES
12 July 1993
GLAXO DRUG MAY OFFER FLU THERAPY
7 June 1993
LONG-TERM CALCITONIN MAINTAINS BONE MASS
19 April 1993
JOUVEINAL PRODUCTS EFFECT ON W-L PIPELINE
8 February 1993
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
